India to Bolivia: Pazopanib Export Trade Route

The India to Bolivia Pazopanib corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $58.4K USD. The route is dominated by BRAWN LABORATORIES LIMITED, which alone accounts for roughly 74% of all export value, reflecting the consolidated nature of India's pazopanib manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $29.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 29.5%, placing it at rank #19 among India's top pazopanib export destinations globally.

On the import side, key buyers of Indian pazopanib in Bolivia include CENTRAL DE ABASTECIMIENTO Y, TO THE MANAGER, MR JESUS GERARDO. CENTRAL DE ABASTECIMIENTO Y is the single largest importer with 1 shipments valued at $43.0K USD.

India's pazopanib exports to Bolivia are driven primarily by a handful of large-scale manufacturers. BRAWN LABORATORIES LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Bolivia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — BRAWN LABORATORIES LIMITED, MHJ PHARMACONCEPTS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $29.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pazpax(pazopanib tablets 200mg) 30 s batch no. patc25a01-a mfg dt-03/2025 exp dt-02/2027, suggesting that buyers in Bolivia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CENTRAL DE ABASTECIMIENTO Y is the largest importer with 1 shipments worth $43.0K USD — representing 74% of all pazopanib imports from India on this route.